After Bristol-Myers Squibb Buys Celgene What's Next? JP Morgan's Conference Will Answer That

For years, Celgene presided as de facto master of ceremonies at the J.P. Morgan Healthcare Conference by being the opening act of this premier life sciences event.  Tens of thousands of healthcare executives and investors have flocked to the conference every year to initiate strategic conversations that set the global healthcare tone for the rest of the business year.  Ironically, it’s also where companies show up to demonstrate how busy they were at the end of the previous year by announcing transactions, sometimes with a whimper, sometimes with a bang.